Albizia for Stress Relief

Research suggests that Albizia julibrissin demonstrates consistent anxiolytic and antidepressant-like effects across multiple preclinical studies, with proposed mechanisms involving the serotonergic system, particularly 5-HT1A receptors, as well as GABAergic pathways and modulation of the HPA axis. Studies conducted in rodent models indicate that various components of the plant, including bark extracts, saponins, julibroside compounds, and lignan glycosides, contribute to these stress-relieving effects through complementary biological mechanisms. The available evidence is supported by several comprehensive reviews published between 2013 and 2025 that document both the traditional use of Albizia for anxiety, melancholy, and insomnia and the emerging pharmacological rationale behind those uses. A notable limitation of the current body of evidence is that it consists almost entirely of animal and laboratory studies, with no human clinical trials identified, meaning the translation of these findings to people remains unestablished and further research is needed before any conclusions about efficacy in humans can be drawn.